Results 251 to 260 of about 2,372,972 (378)

Alteration in Neuregulin 1/ERbB4 in Absence Epilepsy: Regulatory Effect on TRPV1 Expression. [PDF]

Basic Clin Neurosci, 2022
Talebi F, Ghorbani S, Alizadeh L, Akhlaghi F, Sadat Moeeni S, Karimzadeh F.   +5 more
europepmc   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, EarlyView.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Attenuating midline thalamus bursting to mitigate absence epilepsy. [PDF]

Proc Natl Acad Sci U S A
Dong P, Bakhurin K, Li Y, Mikati MA, Cui J, Grill WM, Yin HH, Yang H.   +7 more
europepmc   +1 more source

The Genetic Absence Epilepsy Rats from Strasbourg model of absence epilepsy exhibits alterations in fear conditioning and latent inhibition consistent with psychiatric comorbidities in humans

European Journal of Neuroscience, 2016
W. Marks, M. Cavanagh, Quentin Greba, S. Cain, T. Snutch, J. Howland   +5 more
semanticscholar   +1 more source

Evolving Tale of Childhood Absence Epilepsy: Finally Better News? [PDF]

, 2016
Ajay Gupta
openalex   +1 more source

The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations

British Journal of Clinical Pharmacology, EarlyView.
Spinal muscular atrophy (SMA) is a severe neuromuscular disease with emerging therapeutic complexity. This review aims to systematically map the global pipeline of investigational treatments for SMA. Using ClinicalTrials.gov and complementary international registries, we identified 21 planned or ongoing interventional trials from 2020 to 2025 targeting
Andrej Belančić, Patrick Eustaquio, Elvira Meni Maria Gkrinia, Ivana Stević, Eugen Javor, Yun Wah Lam, Slobodan Janković, Dinko Vitezić   +7 more
wiley   +1 more source

mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data. [PDF]

Curr Neuropharmacol, 2023
Celli R, Striano P, Citraro R, Di Menna L, Cannella M, Imbriglio T, Koko M, De Sarro G, Monn JA, Battaglia G, Luijtelaar GV, Nicoletti F, Russo E, Leo A, EuroEPINOMICS CoGIE Consortium, Palotie A, Folkha AL, Ruppert AK, Siren A, Koeleman B, Lal D, Becker, Caglayan H, Hjalgrim H, Muhle H, Thiele H, Helbig I, Altmuller J, Jabbari K, Everett K, May P, Nürnberg P, Møller R, Nabbout R, Zara F, Scala M, Iacomino M, Scudieri P, Bocciardi R, Balagura G, Minetti C, Riva A, Vari MS, Amadori E, Perinelli M, Verrotti A, Krause R, Balling R, Baulac S, Sander T, Kunz W, Lerche H, Weber Y.   +52 more
europepmc   +1 more source

EFFECT OF PROGRESSIVE ABSENCE EPILEPSY AND ITS TREATMENT ON HEMODYNAMICS AND AUTONOMIC REGULATION OF THE HEART RHYTHM

, 2019
М.Л. Мамалыга, L.M. Mamalyga
openalex   +1 more source

Learning with Patient Campaigners About a German Drug Scandal

Berichte zur Wissenschaftsgeschichte, EarlyView.
The West German drug Duogynon was internationally marketed as a “hormone pregnancy test” (HPT) between the 1950s and 1980s. In the late 1960s it came under suspicion for inducing miscarriage, spina bifida, and a spectrum of birth defects similar to those caused by the sedative thalidomide.
Jesse Olszynko‐Gryn, Anja Suter, Edmund Bolger, Birgit Nemec   +3 more
wiley   +1 more source

Neuronal rhythmicity and cortical arousal in a mouse model of absence epilepsy. [PDF]

Exp Neurol
Khan W, Chopra S, Zheng X, Liu S, Paszkowski P, Valcarce-Aspegren M, Sieu LA, Mcgill S, Mccafferty C, Blumenfeld H.   +9 more
europepmc   +1 more source